Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility (DI-MOB)

April 17, 2026 updated by: Institute of Tropical Medicine, Belgium

Improving Disease Prevention Strategies of Epidemic Spread by Integrating Socio-spatial Characterization of Human Mobility, Environmental Typology and Mathematical Modelling in an Urban System of Cuba

In contrast to the trend expected based on existing prediction models, dengue incidence was historically low during the pandemic mobility restrictions of 2020-2021 in most dengue endemic countries. This highlights that current transmission models do not correctly take human mobility into account. Within a pilot-study in Cienfuegos, South-Central Cuba, we will characterise the epidemiological spread and distribution of dengue outbreaks (2012-2025) in districts repeatedly involved in previous dengue outbreaks as initiating, case-concentrating or transmission sustaining areas. This will be linked with fine-grained mobility data and socio-spatial characterizations of commuting flows and population hubs where people are concentrated during day-time (time when transmission happens). This information, together with entomological and environmental risk-data, will be used to i) improve the accuracy of mathematical dengue models, ii) better understand the transmission process and iii) inform and improve the design of disease control strategies. The project will contribute to much-needed evidence-based guidance for public health actors on improved prevention strategies of epidemics dispersion and where and when to implement control measures.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

Using epidemiological data and human mobility data, integrated with other multiple-sourced data, this study examines the interplay between disease spread and intra-city mobility (within a city).

The study is ambi-spective, using retro- and prospective routine surveillance data (2012-2025) on dengue cases and Aedes entomological data, to describe the fine-scale spatio-temporal characterization of dengue transmission in Cienfuegos municipality.

To characterise human mobility within the municipality of Cienfuegos, information related to recurrent and seasonal movements will be collected. Several types of data will be triangulated to obtain a comprehensive understanding of the population's mobility (matrix of human mobility). In this way, six prospective data collection activities are planned:

  1. Mobility survey: The conduct of a mobility survey with adults. The purpose of this survey is to gather prospective information regarding recurrent mobility, and retrospective information about seasonal mobility. Study subjects include adults, elderly, and indirectly, young children through the specific inclusion of young mothers.
  2. Student survey: Questionnaire about mobility of a sample of students in pre-university and university on recurrent and seasonal mobility.
  3. School registers: Consultation of school registers to capture information on school-related recurrent mobility of children of school-going age.
  4. Vacation stories: Within a two-weeks time after the holidays, teachers are always doing a 'vacation story exercise' within their class. We will ask the teachers of selected classes in the sentinel schools to group this information on the number of children travelling outside the Cienfuegos municipality during holidays (seasonal mobility).
  5. Workplace register: Consultation of workplace registers to capture information on work-related recurrent mobility of adults.
  6. Call Detail Records: Anonymized and grouped information about house-work/school locations of cell phone users obtained from cell phone company (recurrent movement).

In a third step, the above information will be brought into a mathematical model, explaining mobility within transmission dynamics, which will be validated in a prospective way allowing to identify shortcomings and adjust the model where needed.

In a last step, the various types of collected data will be assembled and discussed together for the elaboration of potential dengue (and integrated) control strategies and presented for validation with local stakeholders.

Study Type

Observational

Enrollment (Estimated)

810

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • La Habana
      • Havana, La Habana, Cuba
        • Instituto de Medicina Tropical Pedro Kouri

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Research will take place in Cienfuegos municipality, Cuba, with a population of 178 776 inhabitants. For the epidemiological and entomological data, routine surveillance info will be used, which covers the entire municipality.

For mobility patterns characterisation, for example the mobility survey: we selected (based on epidemiological patterns) 5 sentinel Popular Councils. Within each, 4 consultorios and their area of coverage were selected. In the consultorium exists a health registry, a list of all persons in the consultorium catchment area. Participants will be selected from the health registry by a random process using the RANDBETWEEN function in Microsoft Excel, within a range of 1 to upper limit equal to the total number of patients in the registry.

Description

For the prospective data collection - mobility survey:

Inclusion Criteria:

  • Being a resident of the sentinel Popular Council/consultorio
  • Being >= 19 years of age
  • Being willing and able to provide written informed consent

Exclusion Criteria:

  • being below 19 or above 75 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
dengue incidence
Time Frame: 2012-2025
multilevel spatio-temporal characterization of dengue transmission dynamics, focussing on transmission propagation heterogeneity in time and space
2012-2025
human mobility
Time Frame: 2024-2026
origen-destination matrices will be built, based on information collected in mobility survey, school and workplace registries, vacation stories, phone data, student survey and in-depth interviews
2024-2026

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
entomological risks for dengue transmission
Time Frame: 2012-2025
entomological indicators (monthly data collection of immature stages 2012-2025; monthly surveys of adult stages Aedes mosquitoes 2024-2025)
2012-2025
climate
Time Frame: 2012-2026
temperature (° degrees celsius, daily minimum, daily maximum, weekly average) and rainfall (mm/day)
2012-2026
Mathematical transmission model
Time Frame: 2024-2026
Stochastic mobility-driven spatially explicit DENV model based on the two primary outcomes of this study
2024-2026
socio-spatial characterisation of public spaces
Time Frame: 2024-2026
hourly population densities (number of persons present for more than 5 minutes present) in different rooms/areas of densely frequented public spaces (schools, markets, factories)
2024-2026

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Veerle Vanlerberghe, Institute of Tropical Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

June 30, 2027

Study Registration Dates

First Submitted

August 19, 2024

First Submitted That Met QC Criteria

September 12, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Actual)

April 22, 2026

Last Update Submitted That Met QC Criteria

April 17, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe